Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound

US Patent 6589994 · Granted Jul 8, 2003

Estimated economic value: $15,357,000

Assignee

Inventors

View full patent text on Google Patents →